首页 > 最新文献

Health sciences review (Oxford, England)最新文献

英文 中文
Transforming pediatric speech and language disorder diagnosis and therapy: The evolving role of artificial intelligence 改变儿科言语和语言障碍的诊断与治疗:人工智能不断发展的作用
Pub Date : 2024-06-24 DOI: 10.1016/j.hsr.2024.100188
Ankur Bhardwaj , Mridul Sharma , Sahil Kumar , Sumit Sharma , Prabodh Chander Sharma

Integrating artificial intelligence (AI) with healthcare offers a viable way to treat difficult issues like children's speech-sound disorder (SSD).AAC, or augmentative alternative communication, has shown great promise in helping people with SSD, and AI-driven methods hold even more promise for improving diagnosis and therapy. This review paper explores the synergy of AI, ML, and AAC in pediatric speech and language impairments. It also highlights current developments and potential future directions. Healthcare providers can improve communication outcomes for kids with speech impairments, increase early detection, and provide personalised therapy by utilizing AI and ML techniques. In addition to encouraging parental involvement, the combination of AI and AAC technologies spurs advancements in speech therapy applications. AI has the potential to transform healthcare and improve the quality of life for people with speech and language problems as it develops and works in tandem with medical knowledge.

将人工智能(AI)与医疗保健相结合,为治疗儿童言语-声音障碍(SSD)等疑难问题提供了一种可行的方法。AAC(即辅助替代交流)在帮助言语-声音障碍患者方面已显示出巨大的前景,而人工智能驱动的方法在改善诊断和治疗方面前景更为广阔。本综述论文探讨了人工智能、ML 和 AAC 在儿科言语和语言障碍中的协同作用。它还重点介绍了当前的发展情况和潜在的未来方向。医疗保健提供商可以利用人工智能和 ML 技术改善有语言障碍的儿童的沟通效果,提高早期检测率,并提供个性化治疗。除了鼓励家长参与外,人工智能和 AAC 技术的结合还能促进语言治疗应用的进步。随着人工智能的发展和与医学知识的结合,它有可能改变医疗保健,改善有语言障碍的人的生活质量。
{"title":"Transforming pediatric speech and language disorder diagnosis and therapy: The evolving role of artificial intelligence","authors":"Ankur Bhardwaj ,&nbsp;Mridul Sharma ,&nbsp;Sahil Kumar ,&nbsp;Sumit Sharma ,&nbsp;Prabodh Chander Sharma","doi":"10.1016/j.hsr.2024.100188","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100188","url":null,"abstract":"<div><p>Integrating artificial intelligence (AI) with healthcare offers a viable way to treat difficult issues like children's speech-sound disorder (SSD).AAC, or augmentative alternative communication, has shown great promise in helping people with SSD, and AI-driven methods hold even more promise for improving diagnosis and therapy. This review paper explores the synergy of AI, ML, and AAC in pediatric speech and language impairments. It also highlights current developments and potential future directions. Healthcare providers can improve communication outcomes for kids with speech impairments, increase early detection, and provide personalised therapy by utilizing AI and ML techniques. In addition to encouraging parental involvement, the combination of AI and AAC technologies spurs advancements in speech therapy applications. AI has the potential to transform healthcare and improve the quality of life for people with speech and language problems as it develops and works in tandem with medical knowledge.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"12 ","pages":"Article 100188"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000412/pdfft?md5=c864e0a389ace1998e31ba275221792d&pid=1-s2.0-S2772632024000412-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141582961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transforming multidrug-resistant tuberculosis care: The potentials of telemedicine in resource-limited settings 转变耐多药结核病护理:远程医疗在资源有限环境中的潜力
Pub Date : 2024-06-24 DOI: 10.1016/j.hsr.2024.100185
David B. Olawade , Judith Eberhardt , Aanuoluwapo Clement David-Olawade , Malik A. Balogun , Obasanjo A. Bolarinwa , Deborah T. Esan

Multidrug-resistant tuberculosis (MDR-TB) is a significant public health challenge in low-resource settings owing to limited healthcare access and quality. However, telemedicine can potentially improve healthcare delivery by overcoming geographical barriers. This comprehensive review aimed to provide an overview of the current trends in utilizing telemedicine for MDR-TB control in low-resource settings. A systematic literature search were conducted in PubMed and CINAHL electronic databases and Google Scholar search engine to identify relevant articles on telemedicine and MDR-TB control in low-resource settings. The selected articles were analyzed and synthesized to provide a comprehensive overview of telemedicine's current trends and applications in MDR-TB control. The review results shows that telemedicine allows remote screening and diagnosis, facilitating early detection and timely treatment, provides access to experts through teleconsultation, which ensures optimal treatment outcomes, fosters training and education of healthcare providers, and supports follow-up care through teleconsultation and remote monitoring. Furthermore, telemedicine integration with data collection methods could improve MDR-TB surveillance and intervention. Findings from this review show the potential of telemedicine to improve MDR-TB control and patient health in low-resource settings. This makes it a promising prevention and management option. However, successful implementation requires overcoming limitations such as connectivity, infrastructure, and cultural barriers. Telemedicine can considerably improve MDR-TB control and reduce disease burden in underserved populations by utilizing possibilities and addressing the challenges.

由于医疗服务的可及性和质量有限,耐多药结核病(MDR-TB)是低资源环境下的一项重大公共卫生挑战。然而,远程医疗可以克服地理障碍,改善医疗服务。本综述旨在概述当前在低资源环境中利用远程医疗控制 MDR-TB 的趋势。我们在 PubMed 和 CINAHL 电子数据库以及 Google Scholar 搜索引擎中进行了系统的文献检索,以确定有关远程医疗和低资源环境中 MDR-TB 控制的相关文章。对所选文章进行了分析和综合,以全面概述远程医疗在 MDR-TB 控制中的当前趋势和应用。综述结果表明,远程医疗可进行远程筛查和诊断,从而促进早期发现和及时治疗;通过远程会诊提供与专家接触的机会,从而确保最佳治疗效果;促进对医疗服务提供者的培训和教育;通过远程会诊和远程监测支持后续护理。此外,远程医疗与数据收集方法的整合可以改善对耐药结核病的监测和干预。本综述的研究结果表明,在资源匮乏的环境中,远程医疗具有改善 MDR-TB 控制和患者健康的潜力。这使其成为一种有前景的预防和管理选择。然而,成功实施远程医疗需要克服各种限制,如连接性、基础设施和文化障碍。通过利用各种可能性和应对各种挑战,远程医疗可以大大改善对服务不足人群的耐药结核病控制并减轻疾病负担。
{"title":"Transforming multidrug-resistant tuberculosis care: The potentials of telemedicine in resource-limited settings","authors":"David B. Olawade ,&nbsp;Judith Eberhardt ,&nbsp;Aanuoluwapo Clement David-Olawade ,&nbsp;Malik A. Balogun ,&nbsp;Obasanjo A. Bolarinwa ,&nbsp;Deborah T. Esan","doi":"10.1016/j.hsr.2024.100185","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100185","url":null,"abstract":"<div><p>Multidrug-resistant tuberculosis (MDR-TB) is a significant public health challenge in low-resource settings owing to limited healthcare access and quality. However, telemedicine can potentially improve healthcare delivery by overcoming geographical barriers. This comprehensive review aimed to provide an overview of the current trends in utilizing telemedicine for MDR-TB control in low-resource settings. A systematic literature search were conducted in PubMed and CINAHL electronic databases and Google Scholar search engine to identify relevant articles on telemedicine and MDR-TB control in low-resource settings. The selected articles were analyzed and synthesized to provide a comprehensive overview of telemedicine's current trends and applications in MDR-TB control. The review results shows that telemedicine allows remote screening and diagnosis, facilitating early detection and timely treatment, provides access to experts through teleconsultation, which ensures optimal treatment outcomes, fosters training and education of healthcare providers, and supports follow-up care through teleconsultation and remote monitoring. Furthermore, telemedicine integration with data collection methods could improve MDR-TB surveillance and intervention. Findings from this review show the potential of telemedicine to improve MDR-TB control and patient health in low-resource settings. This makes it a promising prevention and management option. However, successful implementation requires overcoming limitations such as connectivity, infrastructure, and cultural barriers. Telemedicine can considerably improve MDR-TB control and reduce disease burden in underserved populations by utilizing possibilities and addressing the challenges.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"12 ","pages":"Article 100185"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000382/pdfft?md5=aefc45a9a91fc0b78cad95ea8b3c6833&pid=1-s2.0-S2772632024000382-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141483581","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of Vitiligo and its associated risk factors in the middle East and Africa: A systematic review and meta-analysis 中东和非洲的白癜风发病率及其相关风险因素:系统回顾与荟萃分析
Pub Date : 2024-06-24 DOI: 10.1016/j.hsr.2024.100187
Michael Khoury, Toufic Dabit, Hanna Siniora, Julie Fashho, Ahmad A. Toubasi

Vitiligo is a prevalent chronic autoimmune skin disorder. However, the data about its prevalence and risk factors in the Middle East (ME) and Africa is scarce. Thus, we decided to conduct a systematic review and meta-analysis to assess the prevalence and risk factors of vitiligo in the ME and African regions. On the 25th of June 2023 a systematic search of the following database: PubMed, Scopus, Web of Sciences and Cochrane was conducted. All articles were included if they were observational studies that reported the prevalence or risk factors of any type of Vitiligo in one or more ME or African countries with no restriction to the type of vitiligo, age group, or gender. The total number of the included participants was 226,115 from 38 studies. The overall prevalence of vitiligo was 3 % (95 %CI: 2 %-4 %) while the prevalence among males and females were 1 % (95 %CI: 1 %-2 %) and 1 % (95 %CI: 1 %-2 %), respectively. The prevalence among pediatrics was 2 % (95 %CI: 1 %-2 %) while it was 10 % (95 %CI: 7 %-13 %) among adults. The models showed that the prevalence of vitiligo in Africa was 3 % (95 %CI: 1 %-4 %) while the pooled prevalence of vitiligo in Arabian countries was 2 % (95 %CI: 1 %-3 %). Sub-group analysis according to the year of publication showed that the pooled prevalence before 2010 was 3 % (95 %CI: 2 %-4 %). On the other hand, the pooled prevalence after 2010 was 2 % (95 %CI: 1 %-4 %). Clinicians should pay attention to the high prevalence of vitiligo and the characteristics of vitiligo patients. Also, governmental efforts should be taken to increase the awareness about vitiligo in the ME and African countries to increase early diagnosis and management of the disease resulting in better outcomes.

白癜风是一种常见的慢性自身免疫性皮肤病。然而,有关其在中东(ME)和非洲的发病率和风险因素的数据却很少。因此,我们决定进行一次系统回顾和荟萃分析,以评估白癜风在中东和非洲地区的发病率和风险因素。2023 年 6 月 25 日,我们对以下数据库进行了系统检索:PubMed、Scopus、Web of Sciences 和 Cochrane。所有文章只要是报告了一个或多个中东部或非洲国家任何类型白癜风的发病率或风险因素的观察性研究,且不限制白癜风类型、年龄组或性别,均被收录。38项研究共纳入226 115名参与者。白癜风的总发病率为3%(95%CI:2%-4%),男性和女性的发病率分别为1%(95%CI:1%-2%)和1%(95%CI:1%-2%)。儿科患病率为 2 %(95 %CI:1 %-2 %),而成人患病率为 10 %(95 %CI:7 %-13 %)。模型显示,非洲的白癜风患病率为3%(95%CI:1%-4%),而阿拉伯国家的白癜风患病率为2%(95%CI:1%-3%)。根据发表年份进行的分组分析表明,2010年之前的总体发病率为3%(95%CI:2%-4%)。另一方面,2010 年之后的总患病率为 2%(95%CI:1%-4%)。临床医生应关注白癜风的高发病率和白癜风患者的特点。此外,政府应努力提高中东和非洲国家对白癜风的认识,以增加疾病的早期诊断和管理,从而获得更好的治疗效果。
{"title":"The prevalence of Vitiligo and its associated risk factors in the middle East and Africa: A systematic review and meta-analysis","authors":"Michael Khoury,&nbsp;Toufic Dabit,&nbsp;Hanna Siniora,&nbsp;Julie Fashho,&nbsp;Ahmad A. Toubasi","doi":"10.1016/j.hsr.2024.100187","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100187","url":null,"abstract":"<div><p>Vitiligo is a prevalent chronic autoimmune skin disorder. However, the data about its prevalence and risk factors in the Middle East (ME) and Africa is scarce. Thus, we decided to conduct a systematic review and meta-analysis to assess the prevalence and risk factors of vitiligo in the ME and African regions. On the 25th of June 2023 a systematic search of the following database: PubMed, Scopus, Web of Sciences and Cochrane was conducted. All articles were included if they were observational studies that reported the prevalence or risk factors of any type of Vitiligo in one or more ME or African countries with no restriction to the type of vitiligo, age group, or gender. The total number of the included participants was 226,115 from 38 studies. The overall prevalence of vitiligo was 3 % (95 %CI: 2 %-4 %) while the prevalence among males and females were 1 % (95 %CI: 1 %-2 %) and 1 % (95 %CI: 1 %-2 %), respectively. The prevalence among pediatrics was 2 % (95 %CI: 1 %-2 %) while it was 10 % (95 %CI: 7 %-13 %) among adults. The models showed that the prevalence of vitiligo in Africa was 3 % (95 %CI: 1 %-4 %) while the pooled prevalence of vitiligo in Arabian countries was 2 % (95 %CI: 1 %-3 %). Sub-group analysis according to the year of publication showed that the pooled prevalence before 2010 was 3 % (95 %CI: 2 %-4 %). On the other hand, the pooled prevalence after 2010 was 2 % (95 %CI: 1 %-4 %). Clinicians should pay attention to the high prevalence of vitiligo and the characteristics of vitiligo patients. Also, governmental efforts should be taken to increase the awareness about vitiligo in the ME and African countries to increase early diagnosis and management of the disease resulting in better outcomes.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"12 ","pages":"Article 100187"},"PeriodicalIF":0.0,"publicationDate":"2024-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000400/pdfft?md5=1121730b9d14abfe8fa530b7aed5a0eb&pid=1-s2.0-S2772632024000400-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141540872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Trim the fat, trim the risk: Can bariatric surgery prevent breast cancer? "减少脂肪,降低风险:减肥手术能预防乳腺癌吗?
Pub Date : 2024-06-15 DOI: 10.1016/j.hsr.2024.100184
Asad Gul Rao, Neha Pervez
{"title":"Trim the fat, trim the risk: Can bariatric surgery prevent breast cancer?","authors":"Asad Gul Rao,&nbsp;Neha Pervez","doi":"10.1016/j.hsr.2024.100184","DOIUrl":"10.1016/j.hsr.2024.100184","url":null,"abstract":"","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"12 ","pages":"Article 100184"},"PeriodicalIF":0.0,"publicationDate":"2024-06-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000370/pdfft?md5=968b5547eba990aad477b79b7c850334&pid=1-s2.0-S2772632024000370-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141410282","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human health effects associated with occupational and environmental acoustic trauma 职业和环境声创伤对人类健康的影响
Pub Date : 2024-06-10 DOI: 10.1016/j.hsr.2024.100181
Noura Gannouni , Jing Wang , Khémais Ben Rhouma , Abada Mhamdi

Noise is ubiquitous in daily life and can cause both auditory and non-auditory health problems. Noise effects involve both direct and indirect pathways through which noise affects human health. A direct pathway encompasses the interactions between the central auditory system and other regions of the brain. The indirect pathway involves the cognitive and emotional response to a noise-exposure.

This review begins by summarizing both auditory and non-auditory health effects of occupational and environmental noise exposures. It then guides the reader to adequate mitigation strategies and preventive measures to reduce the consequences of noise nuisance.

噪音在日常生活中无处不在,可造成听觉和非听觉健康问题。噪声对人体健康的影响既有直接途径,也有间接途径。直接途径包括中枢听觉系统与大脑其他区域之间的相互作用。本综述首先总结了职业和环境噪声暴露对听觉和非听觉健康的影响。然后,它将指导读者采取适当的缓解策略和预防措施,以减少噪声骚扰的后果。
{"title":"Human health effects associated with occupational and environmental acoustic trauma","authors":"Noura Gannouni ,&nbsp;Jing Wang ,&nbsp;Khémais Ben Rhouma ,&nbsp;Abada Mhamdi","doi":"10.1016/j.hsr.2024.100181","DOIUrl":"10.1016/j.hsr.2024.100181","url":null,"abstract":"<div><p>Noise is ubiquitous in daily life and can cause both auditory and non-auditory health problems. Noise effects involve both direct and indirect pathways through which noise affects human health. A direct pathway encompasses the interactions between the central auditory system and other regions of the brain. The indirect pathway involves the cognitive and emotional response to a noise-exposure.</p><p>This review begins by summarizing both auditory and non-auditory health effects of occupational and environmental noise exposures. It then guides the reader to adequate mitigation strategies and preventive measures to reduce the consequences of noise nuisance.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"12 ","pages":"Article 100181"},"PeriodicalIF":0.0,"publicationDate":"2024-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000345/pdfft?md5=dd271a900242192021b6bac9275e8528&pid=1-s2.0-S2772632024000345-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141402152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
“Is tirofiban the silver bullet for early neurological deterioration in stroke?” "替罗非班是治疗中风早期神经功能恶化的银弹吗?
Pub Date : 2024-06-01 DOI: 10.1016/j.hsr.2024.100180
Asad Gul Rao
{"title":"“Is tirofiban the silver bullet for early neurological deterioration in stroke?”","authors":"Asad Gul Rao","doi":"10.1016/j.hsr.2024.100180","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100180","url":null,"abstract":"","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"11 ","pages":"Article 100180"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000333/pdfft?md5=7afbb11f74c69f794d943baedb73d17b&pid=1-s2.0-S2772632024000333-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141243887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Substantial growth of Health Sciences Review 健康科学评论》大幅增长
Pub Date : 2024-06-01 DOI: 10.1016/j.hsr.2024.100182
Burcin Ekser
{"title":"Substantial growth of Health Sciences Review","authors":"Burcin Ekser","doi":"10.1016/j.hsr.2024.100182","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100182","url":null,"abstract":"","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"11 ","pages":"Article 100182"},"PeriodicalIF":0.0,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000357/pdfft?md5=7f5bd5837c1699cbb5ab067191537500&pid=1-s2.0-S2772632024000357-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141325601","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Best Evidence for exercise management to prevent lymphedema in patients with breast cancer 运动管理预防乳腺癌患者淋巴水肿的最佳证据
Pub Date : 2024-05-29 DOI: 10.1016/j.hsr.2024.100178
Chen Shufang, Wu Sijing, Kuang Yingdie, Xie Zhuoxian

In order to provide nursing staff with optimal exercise interventions for preventing lymphedema in patients with breast cancer, the AGREE II score, the systematic review tool, the literature evaluation criteria and the evidence grading system of the Joanna Briggs Institute (JBI) Center for Evidence-Based Health Care were used to evaluate the included Based on the guidelines, systematic reviews, and expert consensus, 6 people independently evaluated the quality of the literature, and combined with the judgment of personnel with relevant evidence-based nursing knowledge, the qualified literature was evaluated and the evidence grade was assessed. The included research documents are 2 relevant evidence summaries; 1 guideline; 1 expert consensus; 16 systematic reviews, ranging from exercise contraindications, pre-exercise assessment and testing, exercise intensity, exercise safety, exercise programs, precautions, Eight aspects of health education were summarized and analyzed. This article summarizes the exercise intervention measures and management experience for preventing lymphedema in breast cancer patients, providing a basis for nursing staff to guide breast cancer patients to implement exercise intervention measures, thereby effectively preventing the occurrence of lymphedema.

为了给护理人员提供预防乳腺癌患者淋巴水肿的最佳运动干预方法,采用AGREE II评分法、系统综述工具、文献评价标准和Joanna Briggs研究所(JBI)循证医疗中心的证据分级系统对纳入的文献进行评价。 根据指南、系统综述和专家共识,由6人对文献质量进行独立评价,结合具有相关循证护理知识人员的判断,对合格文献进行评价,评定证据等级。纳入的研究文献有相关证据摘要2篇;指南1篇;专家共识1篇;系统综述16篇,从运动禁忌症、运动前评估与检测、运动强度、运动安全性、运动方案、注意事项、健康教育八个方面进行了总结和分析。本文总结了预防乳腺癌患者淋巴水肿的运动干预措施及管理经验,为护理人员指导乳腺癌患者实施运动干预措施提供依据,从而有效预防淋巴水肿的发生。
{"title":"Best Evidence for exercise management to prevent lymphedema in patients with breast cancer","authors":"Chen Shufang,&nbsp;Wu Sijing,&nbsp;Kuang Yingdie,&nbsp;Xie Zhuoxian","doi":"10.1016/j.hsr.2024.100178","DOIUrl":"https://doi.org/10.1016/j.hsr.2024.100178","url":null,"abstract":"<div><p>In order to provide nursing staff with optimal exercise interventions for preventing lymphedema in patients with breast cancer, the AGREE II score, the systematic review tool, the literature evaluation criteria and the evidence grading system of the Joanna Briggs Institute (JBI) Center for Evidence-Based Health Care were used to evaluate the included Based on the guidelines, systematic reviews, and expert consensus, 6 people independently evaluated the quality of the literature, and combined with the judgment of personnel with relevant evidence-based nursing knowledge, the qualified literature was evaluated and the evidence grade was assessed. The included research documents are 2 relevant evidence summaries; 1 guideline; 1 expert consensus; 16 systematic reviews, ranging from exercise contraindications, pre-exercise assessment and testing, exercise intensity, exercise safety, exercise programs, precautions, Eight aspects of health education were summarized and analyzed. This article summarizes the exercise intervention measures and management experience for preventing lymphedema in breast cancer patients, providing a basis for nursing staff to guide breast cancer patients to implement exercise intervention measures, thereby effectively preventing the occurrence of lymphedema.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"12 ","pages":"Article 100178"},"PeriodicalIF":0.0,"publicationDate":"2024-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S277263202400031X/pdfft?md5=73068720fa366bb2b353fbae898e86c9&pid=1-s2.0-S277263202400031X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141542738","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of standard Del Nido cardioplegia for the intracardiac repair of tetralogy of Fallot: A systematic review and meta-analysis of randomized controlled trials 在法洛四联症的心内修复中使用标准德尔尼多心脏麻痹术:随机对照试验的系统回顾和荟萃分析
Pub Date : 2024-05-17 DOI: 10.1016/j.hsr.2024.100179
Shajie Ur Rehman Usmani , Syed Umar Hasan , Syeda Hoorulain Ahmed , Neha Pervez , Amna Zia , Qiudong Chen , George Gill , Georgina Rowe , Saba Alvi , Muhammad Mujeeb Zubair

This meta-analysis compares the efficacy of the standard Del Nido cardioplegia with other agents during intra-cardiac tetralogy of Fallot repair. Meta-analysis was performed on studies comparing standard Del Nido cardioplegia with other types of cardioplegia. Outcomes were pooled using inverse variance and random effects analysis models to calculate the standardized mean difference (SMD) and odds ratio (OR). The SMD for ICU length of stay, duration of mechanical ventilation, and time taken for the heart to return to normal rhythm were -0.06 (P = 0.67), -0.21 (P = 0.06), and 0.23 (P = 0.48), respectively. The OR for the incidence of postoperative arrhythmias was 0.65 (P = 0.32). The standardized mean differences for twenty-four-hour post-operative IL-6, TNF-α, and cTnI levels were 0.29 (P = 0.16), -0.27 (P = 0.01), and -0.60 (P = 0.01), respectively. Del Nido cardioplegia is protective on the myocardium, with lower levels of inflammatory cytokines 24 h post-operation and a significantly reduced incidence of post-operative arrhythmias.

这项荟萃分析比较了标准德尔尼多心脏麻痹与其他药物在法洛氏四联症心内修复过程中的疗效。荟萃分析针对比较标准德尔尼多心脏麻痹与其他类型心脏麻痹的研究进行。使用逆方差和随机效应分析模型对结果进行汇总,计算标准化平均差(SMD)和几率比(OR)。重症监护室住院时间、机械通气持续时间和心脏恢复正常节律所需时间的SMD分别为-0.06(P = 0.67)、-0.21(P = 0.06)和0.23(P = 0.48)。术后心律失常发生率的 OR 值为 0.65 (P = 0.32)。术后 24 小时 IL-6、TNF-α 和 cTnI 水平的标准化平均差异分别为 0.29(P = 0.16)、-0.27(P = 0.01)和-0.60(P = 0.01)。德尔尼多心脏麻痹对心肌具有保护作用,术后 24 小时炎性细胞因子水平较低,术后心律失常的发生率明显降低。
{"title":"Use of standard Del Nido cardioplegia for the intracardiac repair of tetralogy of Fallot: A systematic review and meta-analysis of randomized controlled trials","authors":"Shajie Ur Rehman Usmani ,&nbsp;Syed Umar Hasan ,&nbsp;Syeda Hoorulain Ahmed ,&nbsp;Neha Pervez ,&nbsp;Amna Zia ,&nbsp;Qiudong Chen ,&nbsp;George Gill ,&nbsp;Georgina Rowe ,&nbsp;Saba Alvi ,&nbsp;Muhammad Mujeeb Zubair","doi":"10.1016/j.hsr.2024.100179","DOIUrl":"10.1016/j.hsr.2024.100179","url":null,"abstract":"<div><p>This meta-analysis compares the efficacy of the standard Del Nido cardioplegia with other agents during intra-cardiac tetralogy of Fallot repair. Meta-analysis was performed on studies comparing standard Del Nido cardioplegia with other types of cardioplegia. Outcomes were pooled using inverse variance and random effects analysis models to calculate the standardized mean difference (SMD) and odds ratio (OR). The SMD for ICU length of stay, duration of mechanical ventilation, and time taken for the heart to return to normal rhythm were -0.06 (<em>P</em> = 0.67), -0.21 (<em>P</em> = 0.06), and 0.23 (<em>P</em> = 0.48), respectively. The OR for the incidence of postoperative arrhythmias was 0.65 (<em>P</em> = 0.32). The standardized mean differences for twenty-four-hour post-operative IL-6, TNF-α, and cTnI levels were 0.29 (<em>P</em> = 0.16), -0.27 (<em>P</em> = 0.01), and -0.60 (<em>P</em> = 0.01), respectively. Del Nido cardioplegia is protective on the myocardium, with lower levels of inflammatory cytokines 24 h post-operation and a significantly reduced incidence of post-operative arrhythmias.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"11 ","pages":"Article 100179"},"PeriodicalIF":0.0,"publicationDate":"2024-05-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000321/pdfft?md5=cc70f29df5b9ee667428da07cfd28159&pid=1-s2.0-S2772632024000321-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141039486","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring SK/S1P/S1PR pathway as a target for antiviral drug development 将 SK/S1P/S1PR 通路作为抗病毒药物开发靶点的探索
Pub Date : 2024-05-10 DOI: 10.1016/j.hsr.2024.100177
Sharada Prasanna Swain , Chandra Sekhara Mahanta , Madan Maurya , Debabrata Mandal , Vipan Parihar , V. Ravichandiran

Lysophospholipids are a class of simple phospholipids that shows their biological effects through various G protein-coupled receptors (GPCRs). Sphingosine 1-phosphate (S1P) is one of the most studied lysophospholipid having wide role in various pathophysiological and cellular events, via signalling through five distinct GPCR subtypes, S1P receptors 1–5 (S1PR1-S1PR5).The importance of S1P pathway in drug targets have gained attention significantly after the approval of three S1PR modulators, fngolimod, siponimod and ozanimod, as medicines for patients with multiple sclerosis (MS). S1P, a signal transmitter, is converted to S1P by phosphorylation of Sphingosine kinase (SK1 or SK2) enzymes. S1P acts as an extracellular and intracellular ligand for receptors, S1PR1–5. The SK1/S1P axis and the connected S1PR1–5 plays important roles in many cellular events involving cell signalling, the cell survival/apoptosis, the production of pro-inflammatory cytokine responses, maintaining vascular integrity etc. Further sphingolipids, glycosphingolipids and ceramides acts as receptor/co-receptor for viral entry & downstream signalling, formation of lipid raft-mediated microdomain, viral induced apoptosis. S1P receptor modulator fingolimod shows antiviral activity against human immunodeficiency virus. Currently, the clinical trials of ozanimod (a sphingosine receptor modulator), and opaganib (a SK2inhibitor) are being conducted for treatment of COVID-19. In this review we explored the different roles of sphingolipids, S1P, S1PR, SK in viral infections including a special focus on SARS-CoV2. It is worth to target SK/S1P pathway to develop antiviral drugs, by repurposing existing inhibitors/modulators, and designing new specific inhibitors of SK1, SK2, and SP receptors.

溶血磷脂是一类简单的磷脂,可通过各种 G 蛋白偶联受体(GPCR)显示其生物效应。脑磷脂(S1P)是研究最多的溶血磷脂之一,它通过五种不同的 GPCR 亚型(S1PR1-S1PR5)受体发出信号,在各种病理生理和细胞事件中发挥着广泛的作用。在三种 S1PR 调节剂 fngolimod、siponimod 和 ozanimod 被批准作为治疗多发性硬化症(MS)患者的药物之后,S1P 通路在药物靶点中的重要性受到了广泛关注。S1P 是一种信号传递物质,通过磷酸化脑啡肽激酶(SK1 或 SK2)转化为 S1P。S1P 是 S1PR1-5 受体的细胞外和细胞内配体。SK1/S1P 轴和相连的 S1PR1-5 在细胞信号、细胞存活/凋亡、促炎细胞因子反应的产生、维持血管完整性等许多细胞事件中发挥着重要作用。此外,鞘脂类、糖鞘脂类和神经酰胺还充当病毒进入& 的受体/协同受体;下游信号传导、脂筏介导的微域的形成、病毒诱导的细胞凋亡。S1P 受体调节剂芬戈莫德对人类免疫缺陷病毒具有抗病毒活性。目前,奥扎莫德(一种鞘氨醇受体调节剂)和奥帕加尼布(一种 SK2 抑制剂)正在进行治疗 COVID-19 的临床试验。在这篇综述中,我们探讨了鞘脂类、S1P、S1PR、SK 在病毒感染中的不同作用,包括对 SARS-CoV2 的特别关注。通过重新利用现有的抑制剂/调节剂以及设计新的 SK1、SK2 和 SP 受体特异性抑制剂,以 SK/S1P 通路为目标开发抗病毒药物是值得的。
{"title":"Exploring SK/S1P/S1PR pathway as a target for antiviral drug development","authors":"Sharada Prasanna Swain ,&nbsp;Chandra Sekhara Mahanta ,&nbsp;Madan Maurya ,&nbsp;Debabrata Mandal ,&nbsp;Vipan Parihar ,&nbsp;V. Ravichandiran","doi":"10.1016/j.hsr.2024.100177","DOIUrl":"10.1016/j.hsr.2024.100177","url":null,"abstract":"<div><p>Lysophospholipids are a class of simple phospholipids that shows their biological effects through various G protein-coupled receptors (GPCRs). Sphingosine 1-phosphate (S1P) is one of the most studied lysophospholipid having wide role in various pathophysiological and cellular events, via signalling through five distinct GPCR subtypes, S1P receptors 1–5 (S1PR1-S1PR5).The importance of S1P pathway in drug targets have gained attention significantly after the approval of three S1PR modulators, fngolimod, siponimod and ozanimod, as medicines for patients with multiple sclerosis (MS). S1P, a signal transmitter, is converted to S1P by phosphorylation of Sphingosine kinase (SK1 or SK2) enzymes. S1P acts as an extracellular and intracellular ligand for receptors, S1PR1–5. The SK1/S1P axis and the connected S1PR1–5 plays important roles in many cellular events involving cell signalling, the cell survival/apoptosis, the production of pro-inflammatory cytokine responses, maintaining vascular integrity etc. Further sphingolipids, glycosphingolipids and ceramides acts as receptor/co-receptor for viral entry &amp; downstream signalling, formation of lipid raft-mediated microdomain, viral induced apoptosis. S1P receptor modulator fingolimod shows antiviral activity against human immunodeficiency virus. Currently, the clinical trials of ozanimod (a sphingosine receptor modulator), and opaganib (a SK2inhibitor) are being conducted for treatment of COVID-19. In this review we explored the different roles of sphingolipids, S1P, S1PR, SK in viral infections including a special focus on SARS-CoV2. It is worth to target SK/S1P pathway to develop antiviral drugs, by repurposing existing inhibitors/modulators, and designing new specific inhibitors of SK1, SK2, and SP receptors.</p></div>","PeriodicalId":73214,"journal":{"name":"Health sciences review (Oxford, England)","volume":"11 ","pages":"Article 100177"},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2772632024000308/pdfft?md5=988d81f24632091ba4eedbf40739ac1c&pid=1-s2.0-S2772632024000308-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141035675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Health sciences review (Oxford, England)
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1